Starpharma Holdings Ltd

Starpharma Holdings Ltd

Starpharma Holdings Limited is biotechnology company involved in the research, development and commercialization of dendrimer-based for pharmaceutical, life sciences and other applications. The Company's lead product in development is VivaGel, a microbicide gel for women, for the prevention and treatment of bacterial vaginosis adn a range of sexually transmitted diseases.

Sector Health Technology Sub-Group Biotechnology
Total Shares 369.09 million Market Cap $280.51 million
52 week high $0.86 52-week Low $0.61
1-Year Return 16.92% Relative Return (vsXJO) 12.32%
NTA $50.00 million Price/NTA N/A
ROA -43.85% ROE -52.14%
Next Report N/A Next ex-div N/A
Index Member ASX 300, All Ords, Small Ords
Sector Health Technology
Sub-Group Biotechnology
Total Shares 369.09 million
Market Cap $280.51 million
52 week high $0.86
52-week Low $0.61
1-Year Return 16.92%
Relative Return (vsXJO) 12.32%
NTA $50.00 million
Price/NTA N/A
ROA -43.85%
ROE -52.14%
Next Report N/A
Next ex-div N/A
Index Member ASX 300, All Ords, Small Ords

Speak to a consultant about
Starpharma Holdings Ltd

ENQUIRE NOW

SEARCH FOR COMPANIES

Access our investment insights free

Not understanding the financials of even big blue chips can cost you precious income such as when Telstra reduced their dividends.
This is why our hugely popular Income report has become a must read report for all income investors

Download the Income Report for free to get the top ASX Dividend Stock Recommendations for 2018.

Download Now

We’re here to help

Need to speak to someone about companies or investing?
Our knowledgeable team is on hand to assist